Arlington Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-1,046
| Closed | -$114K | – | 176 |
|
2023
Q4 | $114K | Sell |
1,046
-2,972
| -74% | -$324K | 0.03% | 100 |
|
2023
Q3 | $414K | Sell |
4,018
-1,723
| -30% | -$177K | 0.17% | 64 |
|
2023
Q2 | $662K | Buy |
5,741
+2,180
| +61% | +$252K | 0.1% | 73 |
|
2023
Q1 | $379K | Buy |
3,561
+2,077
| +140% | +$221K | 0.05% | 94 |
|
2022
Q4 | $165K | Buy |
1,484
+382
| +35% | +$42.4K | 0.03% | 108 |
|
2022
Q3 | $95K | Hold |
1,102
| – | – | 0.04% | 141 |
|
2022
Q2 | $100K | Hold |
1,102
| – | – | 0.03% | 161 |
|
2022
Q1 | $90K | Hold |
1,102
| – | – | 0.03% | 194 |
|
2021
Q4 | $84K | Buy |
1,102
+345
| +46% | +$26.3K | 0.02% | 222 |
|
2021
Q3 | $57K | Buy |
757
+512
| +209% | +$38.6K | 0.02% | 243 |
|
2021
Q2 | $19K | Sell |
245
-12
| -5% | -$931 | 0.01% | 248 |
|
2021
Q1 | $19K | Hold |
257
| – | – | 0.01% | 306 |
|
2020
Q4 | $20K | Sell |
257
-448
| -64% | -$34.9K | 0.01% | 149 |
|
2020
Q3 | $56K | Hold |
705
| – | – | 0.03% | 101 |
|
2020
Q2 | $52K | Buy |
705
+203
| +40% | +$15K | 0.03% | 102 |
|
2020
Q1 | $37K | Sell |
502
-366
| -42% | -$27K | 0.02% | 132 |
|
2019
Q4 | $75K | Hold |
868
| – | – | 0.05% | 100 |
|
2019
Q3 | $70K | Hold |
868
| – | – | 0.04% | 90 |
|
2019
Q2 | $69K | Hold |
868
| – | – | 0.03% | 121 |
|
2019
Q1 | $69K | Hold |
868
| – | – | 0.05% | 109 |
|
2018
Q4 | $63K | Buy |
868
+419
| +93% | +$30.4K | 0.04% | 103 |
|
2018
Q3 | $30K | Hold |
449
| – | – | 0.02% | 160 |
|
2018
Q2 | $26K | Sell |
449
-38
| -8% | -$2.2K | 0.02% | 94 |
|
2018
Q1 | $25K | Buy |
+487
| New | +$25K | 0.02% | 98 |
|